1. P122 Treatment with rituximab to demand in rheumatoid arthritis. effectiveness analysis. (21st February 2018) Authors: Julia, U; Fobelo, MJ; Guzman, M Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P146 Golimumab in rheumatoid and psoriatic arthritis. The relationship between minimum serum concentration, anti-golimumab antibodies and activity of disease. (March 2019) Authors: Uceda, J; Fobelo, MJ; Hernandez, R Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PS-101 Risk management of HBV reactivation in haematological patients treated with rituximab. (24th March 2015) Authors: Tristancho, A; Fobelo, MJ; Artacho, S; Jimenez, CJ; Alvaro, S; Manzano, M; Gomez, E; Guzman, MI; Haro, C Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗